Sanofi Challenges J&J’s Darzalex With Blackstone Pact For SC Sarclisa

Could Receive €300m From Private Equity Firm

The French major has entered a risk-sharing collaboration with Blackstone focused on a new formulation of multiple myeloma drug Sarclisa, which could help it take on market leader Darzalex.  

The Competition Could Heat Up For Market Leader Darzalex • Source: Alamy

More from Deals

More from Business